Abstract
Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Current Pharmaceutical Biotechnology
Title: Microbubble: A Potential Ultrasound Tool in Molecular Imaging
Volume: 9 Issue: 5
Author(s): Rajesh M. Patel
Affiliation:
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Abstract: Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Export Options
About this article
Cite this article as:
Patel M. Rajesh, Microbubble: A Potential Ultrasound Tool in Molecular Imaging, Current Pharmaceutical Biotechnology 2008; 9 (5) . https://dx.doi.org/10.2174/138920108785915175
DOI https://dx.doi.org/10.2174/138920108785915175 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sepsis and Solid Organ Transplantation
Current Drug Targets Chemokines in Cardiovascular Remodeling: Clinical and Therapeutic Implications
Current Molecular Medicine A Study on the Specifications of Cold Pressed Colza Oil
Recent Patents on Food, Nutrition & Agriculture The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases
Current Drug Targets Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Current Drug Safety Patent Annotations
Recent Patents on Cardiovascular Drug Discovery Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Lysophosphatidic Acid and Ischemic Stroke
Vascular Disease Prevention (Discontinued) The Roles of Mesenchymal Stem Cells in Tissue Repair and Disease Modification
Current Stem Cell Research & Therapy Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Application of VEGF Gene Therapy in Two Basic Fields of Plastic- Reparative Surgery: Tissue Reconstruction with Flaps and Peripheral Nerve Surgery
Recent Patents on Regenerative Medicine Surgical Treatment of the Sleep Apnea Syndrome in the Twenty-First Century
Current Respiratory Medicine Reviews Editorial [Hot Topic: Matrix Metalloproteinases in Cardiovascular Disease (Guest Editors: N. Papageorgiou & D. Tousoulis)]
Current Topics in Medicinal Chemistry Editorial (Hot Topic: Platelets in Vascular Homeostasis and Inflammation: Current Perspectives from Bench to Bedside)
Current Vascular Pharmacology Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant State
Current Molecular Medicine Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design Role of the Mitochondrial Permeability Transition in Apoptotic and Necrotic Death After Ischemia / Reperfusion Injury to Hepatocytes
Current Molecular Medicine Novel Ideas of Gene Therapy for Atherosclerosis: Modulation of Cellular Signal Transduction of TGF-β Family
Current Pharmaceutical Design What is Tobacco Smoke? Sociocultural Dimensions of the Association with Cardiovascular Risk
Current Pharmaceutical Design